Cargando…
Efficacy of Japanese cedar pollen sublingual immunotherapy tablets for Japanese cypress pollinosis
BACKGROUND: We previously demonstrated the efficacy of Japanese cedar (JC) pollen sublingual immunotherapy (SLIT) tablets for treating seasonal allergic rhinitis in a clinical trial (trial no. 206-2-1) that covered 5 pollen dispersal seasons from 2015 to 2019. OBJECTIVE: Our aim was to perform post...
Autores principales: | Kurokawa, Tomoya, Yonekura, Syuji, Gotoh, Minoru, Okano, Mitsuhiro, Maekawa, Yuriko, Okubo, Kimihiro, Okamoto, Yoshitaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509998/ https://www.ncbi.nlm.nih.gov/pubmed/37780797 http://dx.doi.org/10.1016/j.jacig.2022.10.006 |
Ejemplares similares
-
Same dose of Japanese cedar pollen sublingual immunotherapy tablets is optimal for allergic rhinitis caused by either Japanese cedar or Japanese cypress pollen
por: Gotoh, Minoru, et al.
Publicado: (2022) -
160 Candidate for Response Monitoring or Prognostic Biomarkers in Two-Year Sublingual Immunotherapy for Japanese Cedar Pollinosis
por: Fujimura, Takashi, et al.
Publicado: (2012) -
Complement Factor H Is an Early Predictive Biomarker of the Therapeutic Efficacy of Sublingual Immunotherapy for Japanese Cedar Pollinosis
por: Yoneda, Riyo, et al.
Publicado: (2022) -
Microarray-Based Multivariate Analysis of the Effectiveness of Sublingual Immunotherapy for Cedar Pollinosis
por: Gotoh, Minoru, et al.
Publicado: (2018) -
Decreased numbers of metachromatic cells in nasal swabs in Japanese cedar pollinosis following sublingual immunotherapy
por: Otsuka, Kuninori, et al.
Publicado: (2020)